Page last updated: 2024-10-29

ketamine and Diffuse Mixed Small and Large Cell Lymphoma

ketamine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fynn, RW1

Other Studies

1 other study available for ketamine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Ketamine in the management of a case of lymphosarcoma cutis.
    British journal of anaesthesia, 1974, Volume: 46, Issue:9

    Topics: Ambulatory Care; Combined Modality Therapy; Female; Humans; Infant; Ketamine; Lymphoma, Non-Hodgkin;

1974